Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

TB-Dar

ABSTRACT: Tuberculosis epidemic in Dar es Salaam, Tanzania

PROVIDER: PRJEB49562 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	ERR12866100.fastq.gz	Fastqsanger.gz
	ERR12866200.fastq.gz	Fastqsanger.gz
	ERR12866300.fastq.gz	Fastqsanger.gz
	ERR12866400.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 2011

Similar Datasets

TB-DAR Whole Genome Sequencing Study

Project description:116 Whole Genome Sequencing (WGS) samples from the TB-DAR study, which consists of a cohort of adult pulmonary tuberculosis patients recruited in Dar es Salaam, Tanzania.

| EGAS00001005850 | EGA

TB-DAR Genotyping Study

Project description:Active TB patients (sputum smear-positive and GeneXpert-positive) recruited at the Temeke District Hospital in Dar es Salaam, Tanzania, as part of a prospective study that ran between November 2013 and June 2022 (TB-DAR cohort).

| EGAS00001007216 | EGA

TB-DAR Genotyping Study

| EGAD00010002507 | EGA

Mkango2019 - Dynamics of Breast Cancer under DifferentRates of Chemoradiotherapy

Project description:Dynamics of Breast Cancer under Different Rates of Chemoradiotherapy. Mkango SB1, Shaban N1, Mureithi E1, Ngoma T2. Author information 1 Department of Mathematics, University of Dar es Salaam, P.O. Box 35062, Dar es Salaam, Tanzania. 2 Department of Clinical Oncology, Muhimbili University of Health and Allied Sciences, P.O. Box 65000, Dar es Salaam, Tanzania. Abstract A type of cancer which originates from the breast tissue is referred to as breast cancer. Globally, it is the most common cause of death in women. Treatments such as radiotherapy, chemotherapy, hormone therapy, immunotherapy, and gene therapy are the main strategies in the fight against breast cancer. The present study aims at investigating the effects of the combined radiotherapy and chemotherapy as a way to treat breast cancer, and different treatment approaches are incorporated into the model. Also, the model is fitted to data on patients with breast cancer in Tanzania. We determine new treatment strategies, and finally, we show that when sufficient amount of chemotherapy and radiotherapy with a low decay rate is used, the drug will be significantly more effective in combating the disease while health cells remain above the threshold. Copyright © 2019 Sara B. Mkango et al.

2020-01-20 | MODEL1912120005 | BioModels

Klebsiella pneumoniae

Project description:Klebsiella pneumoniae carriage in Dar es Salaam, Tanzania

| PRJNA503964 | ENA

Host blood-based biosignatures for subclinical TB: a prospective study of household contacts of adult pulmonary TB index cases in Southern India.

Project description:Identification of blood transcriptional biomarkers linked to different phases of tuberculosis. The discovery of a transcriptional signature that distinguishes subclinical TB from incipient TB at baseline could lead to tuberculosis interventions that combat the tuberculosis epidemic in the context of household contacts.

2023-01-10 | GSE193777 | GEO

Bacillus thuringiensis dar 81934

Project description:Bacillus thuringiensis DAR 81934 genome sequencing

| PRJNA303248 | ENA

Bacillus thuringiensis DAR 81934

Project description:Bacillus thuringiensis DAR 81934 Genome sequencing and assembly

| PRJNA179326 | ENA

Elsinoe fawcettii isolate:DAR-70024

Project description:Elsinoe fawcettii isolate:DAR-70024 Genome sequencing and assembly

| PRJNA534185 | ENA

4b3b593d-644f-401f-9a3b-a3faa028ce24 - samples

Project description:116 Whole Genome Sequencing (WGS) samples from the TB-DAR study, based on a cohort of adult pulmonary tuberculosis patients recruited in Dar es Salaam, Tanzania. WGS was performed at the Health2030 Genome Center in Geneva on the Illumina NovaSeq 6000 instrument (Illumina Inc, San Diego CA, USA), starting from1ÃŽÂ¼g of whole blood genomic DNA and using Illumina TruSeq DNA PCR-Free reagents for library preparation and the 150nt paired-end sequencing configuration. Average coverage was above 30X for 75 samples, between 10X and 30Xfor 40 samples, and approximately 8X for a single sample. Sequencing reads were aligned to the GRCh38 (GCA_000001405.15) reference genome using bwa (Version 0.7.17).

| EGAD00001008400 | EGA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data